To describe the natural history of SARS-CoV-2 infection in patients with hypertrophic cardiomyopathy (HCM) compared with a control group and to identify predictors of adverse events.
Impact of SARS-Cov-2 infection in patients with hypertrophic cardiomyopathy: results of an international multicentre registry / Gimeno, Juan R; Olivotto, Iacopo; Rodríguez, Ana Isabel; Ho, Carolyn Y; Fernández, Adrián; Quiroga, Alejandro; Espinosa, Mari Angeles; Gómez-González, Cristina; Robledo, María; Tojal-Sierra, Lucas; Day, Sharlene M; Owens, Anjali; Barriales-Villa, Roberto; Larrañaga, Jose María; Rodríguez-Palomares, Jose; González-Del-Hoyo, Maribel; Piqueras-Flores, Jesús; Reza, Nosheen; Chumakova, Olga; Ashley, Euan A; Parikh, Victoria; Wheeler, Matthew; Jacoby, Daniel; Pereira, Alexandre C; Saberi, Sara; Helms, Adam S; Villacorta, Eduardo; Gallego-Delgado, María; de Castro, Daniel; Domínguez, Fernando; Ripoll-Vera, Tomás; Zorio-Grima, Esther; Sánchez-Martínez, José Carlos; García-Álvarez, Ana; Arbelo, Elena; Mogollón, María Victoria; Fuentes-Cañamero, María Eugenia; Grande, Elias; Peña, Carlos; Monserrat, Lorenzo; Lakdawala, Neal K. - In: ESC HEART FAILURE. - ISSN 2055-5822. - STAMPA. - 9:(2022), pp. 2189-2198. [10.1002/ehf2.13964]
Impact of SARS-Cov-2 infection in patients with hypertrophic cardiomyopathy: results of an international multicentre registry
Olivotto, Iacopo;
2022
Abstract
To describe the natural history of SARS-CoV-2 infection in patients with hypertrophic cardiomyopathy (HCM) compared with a control group and to identify predictors of adverse events.
| File | Dimensione | Formato | |
|---|---|---|---|
|
impact_sars_cov_2_infection_patients_hypertrophic_cardiomyopathy_results_an_international_multicentre_registry_2022.pdf
accesso aperto
Tipologia:
Pdf editoriale (Version of record)
Licenza:
Open Access
Dimensione
1.56 MB
Formato
Adobe PDF
|
1.56 MB | Adobe PDF |
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
